Literature DB >> 24338621

SYNTAX-justified trend toward restricting coronary artery bypass grafting to more serious cases.

Mamoru Arakawa1, Atsushi Yamaguchi, Kenichi Sakakura, Homare Okamura, Junya Ako, Shin-Ichi Momomura, Hideo Adachi.   

Abstract

OBJECTIVE: Since drug-eluting stents (DESs) appeared in Japan, coronary artery bypass grafting (CABG) has been indicated for more severe lesions. To understand the implications of this trend, we compared SYNTAX scores in two groups of patients treated with CABG before and after DESs approval.
METHODS: Consecutive CABG patients during January 2001-July 2003 (pre-DES era patients, n = 160) and January 2008-July 2010 (DES era patients, n = 103) were included. The SYNTAX scores of both groups were compared and a cardiologist retrospectively re-evaluated coronary angiograms to determine whether CABG or percutaneous coronary intervention (PCI) would be recommended under current standards.
RESULTS: SYNTAX scores were significantly higher in DES era group compared with pre-DES era group (33.3 ± 10.6 vs. 28.1 ± 10.6, p < 0.01). Percutaneous coronary intervention would be the preferred treatment option in 66 (41 %) of pre-DES patients, whose SYNTAX scores were significantly lower than those of patients who were considered good candidates for CABG (21.9 ± 9.3 vs. 32.5 ± 9.1, p < 0.01).
CONCLUSIONS: Although CABG is now being performed in intermediate-to-highly complex cases, DES era outcomes, including operative mortality and early graft failure, have not worsened in comparison to the pre-DES era.

Entities:  

Mesh:

Year:  2013        PMID: 24338621     DOI: 10.1007/s11748-013-0360-z

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN: 1863-6705


  25 in total

1.  SYNTAX score and Clinical SYNTAX score as predictors of very long-term clinical outcomes in patients undergoing percutaneous coronary interventions: a substudy of SIRolimus-eluting stent compared with pacliTAXel-eluting stent for coronary revascularization (SIRTAX) trial.

Authors:  Chrysafios Girasis; Scot Garg; Lorenz Räber; Giovanna Sarno; Marie-Angèle Morel; Hector M Garcia-Garcia; Thomas F Lüscher; Patrick W Serruys; Stephan Windecker
Journal:  Eur Heart J       Date:  2011-09-27       Impact factor: 29.983

2.  Initial clinical impact of drug eluting stents on coronary artery bypass graft surgery.

Authors:  Shinji Kanemitsu; Keizo Tanaka; Jin Tanaka; Hitoshi Suzuki; Toshihiko Kinoshita
Journal:  Interact Cardiovasc Thorac Surg       Date:  2007-07-04

3.  Initial impact of drug-eluting stents on coronary artery bypass graft surgery.

Authors:  John R Liddicoat; Ralph De La Torre; Kalon K L Ho; Senthil Nathan; Sidney Levitsky; Judy Krempin; Frank Sellke
Journal:  Ann Thorac Surg       Date:  2006-04       Impact factor: 4.330

4.  Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial.

Authors:  Friedrich W Mohr; Marie-Claude Morice; A Pieter Kappetein; Ted E Feldman; Elisabeth Ståhle; Antonio Colombo; Michael J Mack; David R Holmes; Marie-angèle Morel; Nic Van Dyck; Vicki M Houle; Keith D Dawkins; Patrick W Serruys
Journal:  Lancet       Date:  2013-02-23       Impact factor: 79.321

5.  Guidelines for elective percutaneous coronary intervention in patients with stable coronary artery disease (JCS 2011) published in 2012--digest version.

Authors: 
Journal:  Circ J       Date:  2013-05-09       Impact factor: 2.993

6.  Risk stratification in heart surgery: comparison of six score systems.

Authors:  H J Geissler; P Hölzl; S Marohl; F Kuhn-Régnier; U Mehlhorn; M Südkamp; E R de Vivie
Journal:  Eur J Cardiothorac Surg       Date:  2000-04       Impact factor: 4.191

Review 7.  The conundrum of late and very late stent thrombosis following drug-eluting stent implantation.

Authors:  Pallav Garg; Laura Mauri
Journal:  Curr Opin Cardiol       Date:  2007-11       Impact factor: 2.161

8.  Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease.

Authors:  Patrick W Serruys; Marie-Claude Morice; A Pieter Kappetein; Antonio Colombo; David R Holmes; Michael J Mack; Elisabeth Ståhle; Ted E Feldman; Marcel van den Brand; Eric J Bass; Nic Van Dyck; Katrin Leadley; Keith D Dawkins; Friedrich W Mohr
Journal:  N Engl J Med       Date:  2009-02-18       Impact factor: 91.245

Review 9.  Systematic review: the comparative effectiveness of percutaneous coronary interventions and coronary artery bypass graft surgery.

Authors:  Dena M Bravata; Allison L Gienger; Kathryn M McDonald; Vandana Sundaram; Marco V Perez; Robin Varghese; John R Kapoor; Reza Ardehali; Douglas K Owens; Mark A Hlatky
Journal:  Ann Intern Med       Date:  2007-10-15       Impact factor: 25.391

10.  Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug-eluting stents for patients with multivessel coronary artery disease.

Authors:  Aamir Javaid; Daniel H Steinberg; Ashesh N Buch; Paul J Corso; Steven W Boyce; Tina L Pinto Slottow; Probal K Roy; Peter Hill; Teruo Okabe; Rebecca Torguson; Kimberly A Smith; Zhenyi Xue; Natalie Gevorkian; William O Suddath; Kenneth M Kent; Lowell F Satler; Augusto D Pichard; Ron Waksman
Journal:  Circulation       Date:  2007-09-11       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.